Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma

Ampersand Biosciences was cited in the article titled, “Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma” for the use of Rodent Map 4.0 on the Luminex platform to measure mouse plasma and cell supernatant cytokines. Analysis was performed on 42 analytes including: Analysis of 42 analytes; CCL6, CRP, Eotaxin, GCP-2, GMCSF, IFN?, IFN?, IL1?, IL1 beta, IL2, IL4, IL5, IL6, IL9, IL10, IL12p40, IL12p70, IL17A, IL18, IL23, IL27, IL28, Insulin, IP-10, KC/GRO, MCP-1, MCSF1, MDC, MIP-1?, MIP-1?, MIP-1?, MMP-9, NGAL, RAGE, PAI-1, SCF, TIMP-1, TNF?, TPO, TSLP, VCAM-1, VEGF-A.

Species: Mouse
Focus: T-Cell Lymphoma